Considerations for implementation of novel enzyme-based processes [PDF]
, 2017 Deslauriers, Maria Gundersen
core
Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice. [PDF]
Nat MedKrüger N +8 more
europepmc +1 more source
Development and Validation of a Highly Sensitive LC-MS/MS Method for the Precise Quantification of Sitagliptin in Human Plasma and Its Application to Pharmacokinetic Study. [PDF]
MoleculesSong Y +7 more
europepmc +1 more source
Enhanced meropenem activity and stability following load in Polyvinyl alcohol nanofiber scaffolds with sitagliptin as quorum sensing inhibitor on Pseudomonas aeruginosa. [PDF]
J Biol EngMohsen AA +3 more
europepmc +1 more source
Sitagliptin as a therapeutic approach for social anxiety disorder: the role of DPP4 and NPY in modulating social fear and comorbid depressive-like behavior in mice. [PDF]
NeuropsychopharmacologyZoicas I +4 more
europepmc +1 more source
Impact of baseline alanine aminotransferase levels on the efficacy of dapagliflozin and sitagliptin: Latent class analysis from the DIVERSITY-CVR study. [PDF]
Diabetes Obes MetabMochizuki K +3 more
europepmc +1 more source
Renal Dysfunction in a Patient with a Roux-en-Y Gastric Bypass Surgery [PDF]
, 2014 Carvalho, F +4 more
core
Anti-osteoporotic effect of sitagliptin in an osteoporosis model of ovariectomized rats: role of RUNX2 and RANKL/OPG ratio. [PDF]
Naunyn Schmiedebergs Arch PharmacolEl-Marasy SA +4 more
europepmc +1 more source
DPP4 inhibitors as a novel therapeutic strategy in colorectal cancer: Integrating network biology and experimental insights. [PDF]
PLoS OneBardaweel SK +3 more
europepmc +1 more source
Efficacy and Safety of Triple Fixed Dose Combination of Dapagliflozin + Sitagliptin + Metformin IR in Indian Patients with Type 2 Diabetes Mellitus: A Randomized, Phase 3 Study in Comparison with Dual FDC Sitagliptin + Metformin IR. [PDF]
Adv TherSingh MP +15 more
europepmc +1 more source